Genmab | GEN - Capitaux D'Emprunt

Prix De L'Action
1,790.50
Variation Quotidienne
0.50 0.03%
Mensuellement
6.58%
Annuel
37.94%
Q2 Prévisions
1,699.78




Capitaux D'Emprunt Changement Date
Agios Pharmaceuticals USD 1.06M 0 2022-09
Almirall EUR 324.81M 61.32M 2025-12
Amgen USD 50B 2.43B 2025-12
argenx SE USD 35.57M 3.05M 2025-06
AstraZeneca USD 26.14B 19.58B 2025-12
Bayer EUR 31.83B 877M 2025-12
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Demant DKK 18.98B 3.71B 2025-12
Fresenius Medical Care EUR 4.85B 4.49B 2025-12
Galapagos EUR 5.19M 574K 2025-12
Genmab DKK 5.14B 5.01B 2025-12
GlaxoSmithKline GBP 14.71B 186M 2025-12
GN Store Nord DKK 8.9B 9M 2025-12
GRIFOLS EUR 8.47B 624.81M 2025-12
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Insmed USD 540.96M 1.24M 2025-12
Lonza CHF 3.88B 323M 2025-12
Merck EUR 10.73B 277M 2025-12
Novartis USD 29.59B 5.35B 2025-12
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 15.72B 2.45B 2025-12
UCB EUR 2.18B 634M 2025-12